Insulin secretory granules labelled with phogrin-fluorescent proteins show alterations in size, mobility and responsiveness to glucose stimulation in living β-cells.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
27 02 2019
27 02 2019
Historique:
received:
06
09
2018
accepted:
15
01
2019
entrez:
1
3
2019
pubmed:
1
3
2019
medline:
22
9
2020
Statut:
epublish
Résumé
The intracellular life of insulin secretory granules (ISGs) from biogenesis to secretion depends on their structural (e.g. size) and dynamic (e.g. diffusivity, mode of motion) properties. Thus, it would be useful to have rapid and robust measurements of such parameters in living β-cells. To provide such measurements, we have developed a fast spatiotemporal fluctuation spectroscopy. We calculate an imaging-derived Mean Squared Displacement (iMSD), which simultaneously provides the size, average diffusivity, and anomalous coefficient of ISGs, without the need to extract individual trajectories. Clustering of structural and dynamic quantities in a multidimensional parametric space defines the ISGs' properties for different conditions. First, we create a reference using INS-1E cells expressing proinsulin fused to a fluorescent protein (FP) under basal culture conditions and validate our analysis by testing well-established stimuli, such as glucose intake, cytoskeleton disruption, or cholesterol overload. After, we investigate the effect of FP-tagged ISG protein markers on the structural and dynamic properties of the granule. While iMSD analysis produces similar results for most of the lumenal markers, the transmembrane marker phogrin-FP shows a clearly altered result. Phogrin overexpression induces a substantial granule enlargement and higher mobility, together with a partial de-polymerization of the actin cytoskeleton, and reduced cell responsiveness to glucose stimulation. Our data suggest a more careful interpretation of many previous ISG-based reports in living β-cells. The presented data pave the way to high-throughput cell-based screening of ISG structure and dynamics under various physiological and pathological conditions.
Identifiants
pubmed: 30814595
doi: 10.1038/s41598-019-39329-5
pii: 10.1038/s41598-019-39329-5
pmc: PMC6393586
doi:
Substances chimiques
Sweetening Agents
0
enhanced green fluorescent protein
0
Green Fluorescent Proteins
147336-22-9
Ptprn2 protein, rat
EC 3.1.3.48
Receptor-Like Protein Tyrosine Phosphatases, Class 8
EC 3.1.3.48
Glucose
IY9XDZ35W2
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2890Références
Proc Natl Acad Sci U S A. 2004 Jun 22;101(25):9266-71
pubmed: 15197259
Diabetologia. 2012 Apr;55(4):1013-23
pubmed: 22252472
PLoS One. 2014 Oct 13;9(10):e109082
pubmed: 25310693
Nat Methods. 2014 Mar;11(3):281-9
pubmed: 24441936
Curr Biol. 1999 Aug 26;9(16):915-8
pubmed: 10469598
Biochem J. 2004 Jul 1;381(Pt 1):13-8
pubmed: 15128287
Vitam Horm. 2009;80:473-506
pubmed: 19251047
Proc Natl Acad Sci U S A. 2007 Oct 2;104(40):15841-6
pubmed: 17898179
Diabetologia. 1993 Nov;36(11):1139-45
pubmed: 8270128
Traffic. 2004 Oct;5(10):750-62
pubmed: 15355511
Proc Natl Acad Sci U S A. 2009 May 5;106(18):7432-6
pubmed: 19372374
Biophys J. 2005 May;88(5):3601-14
pubmed: 15722439
Sci Rep. 2017 Nov 1;7(1):14836
pubmed: 29093485
Sci Data. 2018 Sep 18;5:180191
pubmed: 30226484
J Clin Invest. 2011 Jun;121(6):2118-25
pubmed: 21633180
J Cell Sci. 2005 Dec 15;118(Pt 24):5873-84
pubmed: 16317050
Diabetes. 2009 May;58(5):e8
pubmed: 19401431
Acta Biomater. 2016 Sep 15;42:189-198
pubmed: 27449340
J Vis Exp. 2014 Oct 09;(92):e51994
pubmed: 25350683
Nature. 2018 Aug;560(7716):107-111
pubmed: 30022165
Sci Rep. 2017 Oct 18;7(1):13445
pubmed: 29044173
J Biol Chem. 2003 Dec 26;278(52):52042-51
pubmed: 14532293
Diabetologia. 2003 Aug;46(8):1029-45
pubmed: 12879249
Endocrinology. 1992 Jan;130(1):167-78
pubmed: 1370150
Traffic. 2012 Nov;13(11):1466-80
pubmed: 22889194
Eur Biophys J. 2000;29(2):67-89
pubmed: 10877017
Nat Commun. 2014 Dec 23;5:5891
pubmed: 25532887
Mol Endocrinol. 2003 Apr;17(4):732-42
pubmed: 12554769
PLoS One. 2010 Sep 23;5(9):e12929
pubmed: 20886068
J Endocrinol. 2005 Apr;185(1):57-67
pubmed: 15817827
Am J Pathol. 1999 Apr;154(4):1077-88
pubmed: 10233846
Proc Natl Acad Sci U S A. 2013 Jul 23;110(30):12307-12
pubmed: 23836651
Biochem Biophys Res Commun. 2018 Sep 18;503(4):2710-2714
pubmed: 30119894
J Biol Chem. 2002 Sep 13;277(37):34168-75
pubmed: 12101177
EMBO J. 2016 Jan 4;35(1):62-76
pubmed: 26620550
Science. 2015 Feb 20;347(6224):878-82
pubmed: 25700520
Trends Endocrinol Metab. 2010 Oct;21(10):599-609
pubmed: 20609596
Nanomedicine (Lond). 2017 Feb;12(4):403-416
pubmed: 28000542
J Biol Chem. 2010 Apr 2;285(14):10487-96
pubmed: 20097759
Proc Natl Acad Sci U S A. 2013 Mar 26;110(13):4911-6
pubmed: 23479621
Proc Natl Acad Sci U S A. 2005 May 24;102(21):7523-8
pubmed: 15897455
J Biol Chem. 1990 Mar 15;265(8):4173-6
pubmed: 2407732
Proc Natl Acad Sci U S A. 2015 Feb 17;112(7):E667-76
pubmed: 25646459
Biochem Biophys Res Commun. 2018 Sep 18;503(4):2704-2709
pubmed: 30100062